Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.15 1.63% 9.35 9.20 9.50 9.35 9.35 9.35 656,600 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 12.1 -6.1 -1.1 - 40

Kromek Share Discussion Threads

Showing 5426 to 5448 of 6625 messages
Chat Pages: Latest  229  228  227  226  225  224  223  222  221  220  219  218  Older
DateSubjectAuthorDiscuss
02/10/2021
16:41
Interesting FT article from a couple of weeks ago.

Bioterror: the dangers of garage scientists manipulating DNA

"These garage scientists might seem like a quirky new subculture but their rogue mindset is starting to generate consternation among those who specialise in managing biological threats in governments and international bodies.

In 2018 the states that are signatories to the 1972 Biological Weapons Convention (BWC) identified gene editing, gene synthesis, gene drives and metabolic pathway engineering as research that qualifies as “dual use”, meaning it is as easy to deploy for harmful purposes as it is for good.

Many of the parties are now worried that increased accessibility to such technologies could heighten accidental or deliberate misuse, including the development of biological weapons by rogue actors for mass or targeted attacks.

hTTps://www.ft.com/content/9ac7f1c0-1468-4dc7-88dd-1370ead42371

33mick
02/10/2021
11:04
33 dot you know why
ali47fish
02/10/2021
10:06
Kromek have had more coverage in Korea
than here....

hTTps://youtu.be/tA1JmoHnclc

33mick
02/10/2021
09:49
세상/564;사] 영국 발명,032;, 공기 중 코로-208;바이러스 탐지 장비 개발

Good video of the recent exhibition and some other lab areas.

Who can read Korean?

hTTps://m.science.ytn.co.kr/view.php?s_mcd=0082&s_hcd=&key=202110011638363590

33mick
30/9/2021
12:50
Oxford Nanopore soars 42% in conditional trading upon market debut today.
quepassa
30/9/2021
07:24
Can someone get the nurse for retirementfund please. Looks like he’s out of bed.
b00mb0y
29/9/2021
21:57
Momentum is returning here good to see the new order and the holdings RNS's. Would be nice to see a couple more orders and then will break out
retirementfund
29/9/2021
21:39
Schrieber post on lse is bang on.
b00mb0y
29/9/2021
18:34
Nice to see Newlands faith given their experience and background…
strategicinvestor2
29/9/2021
16:10
monique newland increases holding- is she a director?
ali47fish
28/9/2021
18:08
It’s easy to forget why I bought into Kromek... the business taking a turn and due to make a profit (despite the large spend on IP). Plus the potential of the biological pathogen detector. To sell now as tempting as it is sometimes, as the share price is heading down with no obvious reasons or news - is as Warren Buffet would say ‘watching the scoreboard instead of the pitch’.
aqc888
28/9/2021
08:25
Well there's some appetite for Kromek this morning(yesterday pm) that's 3 x 100k & a delayed 250k from 8.01am. And plenty of other buys too.
I'm holding out until the end of the year too, atleast. Surely has to be some positive update by then!?!

davethechef
28/9/2021
08:02
It gave me some comfort to see Kromek have been patenting a lot in the last year. Mostly to do with the biological pathogen detector I presume. I’m a lot happier holding through these dips knowing that not only are they having their best financial year (not due to make a loss!) 80% of analysts forecast for the financial year already met, despite the spend on being 4th in the Intellectual Property 100 list.
aqc888
27/9/2021
23:31
Can anyone explain why its been implied in interviews and emails to investors that the Covid detector works fantastically well but they haven’t bothered to RNS what on earth is going on right now?

Another 6 weeks minimum now of nothing. Is the thing finished but struggling to find buyers or is it still being tweaked? What is going on??? There unprofessionalism in regards to updating the market has caused a sell off. I’ve sold half myself these last few weeks and seems like many others have also. Maybe they want us to sell before they announce a huge order? Maybe there are no orders? Smoke and mirrors ?

ark87
27/9/2021
23:31
kmk have some great tech but the orders are usually small. The question I am starting to ask myself is when you factor in overheads are they making this great technology AT A LOSS??

I’ve done enough moaning here now will be my last post. I’ll be back to apologise if we ever do see serious upwards movement in the share price

ark87
27/9/2021
21:14
So Covid will probably morph into something like the common cold in the usual couple of years time frame - an H5N7 flu strain could be a real worry for the future and a vaccine for HIV could be a long way off.

IMO GLA

simithy
27/9/2021
15:55
as they cant buy during a closed period, any director buys inadvertently means nothing price sensitive happening for at least 6 weeks.
Otherwise the purchase would be under scrutiny

fanramptastic mate
27/9/2021
15:32
If it’s the start of a flurry of director buys it could have a positive effect. However I’d be a lot more at ease knowing they’ve invested more significant amounts. £50k buys would make me happier
aqc888
27/9/2021
15:29
A token gesture. What exactly are the regulations for insiders such as this director buying shares, when he must surely have access to detailed information on how the detectors progress is going? Better details than the market.
aqc888
27/9/2021
15:29
Directors buy- seems to show insiders confidence
strategicinvestor2
27/9/2021
13:36
£15k Directors buy. Seems like desperate attempt to stop the selling.
ark87
27/9/2021
12:37
Indeed.

The Sciences and scientists tend to be highly specialised.

Very, very rare that they are inter-disciplinary in my experience.

CZT is one field and one specialisation - which is clearly the core activity and apparent strategy of Kromek.

But a new product based on a fundamentally different branch of science - biotechnology- involving DNA-Sequencing is something completely different from CZT based applications.

I'd personally like to understand better the resources and commitment - financial, technical and human - that the Company has to support a new development based on a biotech product and how many dedicated DNA-Sequencing specialists/ biotechnologists they have to develop and support this new activity.

all imo.dyor.
qp

quepassa
27/9/2021
12:16
And seemingly unaware of the very differing challenges a error correcting retro virus - Covid, a genetically diverse virus - flu and a mutation engine HIV pose.
simithy
Chat Pages: Latest  229  228  227  226  225  224  223  222  221  220  219  218  Older
Your Recent History
LSE
KMK
Kromek
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221127 09:48:49